Final program

 


CME

 

The Continuing Professional Development (CPD) Office of the Faculty of Medicine of the University of Montreal is fully accredited by the Association of Faculties of Medicine of Canada (AFMC) and from the Quebec College of Physicians.

The Continuing Professional Development (CPD) Office of the Faculty of Medicine of Université de Montréal, a fully certified CPD provider by the Collège des médecins du Québec, recognizes 19 hour(s) of category 1 credits to participants of this activity.

 

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and has been approved by the CPD Office of the Faculty of medicine of Université de Montréal for a maximum of 19 hour(s).


For all other participating professionals, this program provides a certificate of participation of 19 hour(s).

 

This activity is accredited for a maximum of 19 hour(s).

 

Participants must claim the number of hours according to their participation.



The aim of the conference is to:

  • Provide physicians, clinicians, researchers, and other healthcare professionals with a platform to discuss advances and innovations in the study of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome.
  • Develop, with the help of an international coalition of ME experts, a sustainable ME/CFS research agenda.

 

This three-day conference will consist of:

 

Day 1 - Healthcare community

A Medical Education Symposium open to the healthcare community. Topics will include an overview of ME/CFS and how to diagnose and manage the disease.

 

Day 2 - Healthcare community and patients

The following sessions are for HEALTHCARE COMMUNITY:

  • Opening remarks and Plenary Lectures 1 & 2 | Amphitheatre 250
  • Session 1A - Genetics, Genomics and Epigenetics | Amphitheatre 125
  • Session 2A - Biochemistry, Metabolomics and Proteomics | Amphitheatre 125
  • Session 3A - Infection, Immunity and Clinical research | Amphitheatre 125
  • Session 4A (partie 1) - Biomarkers, Biobanking, and Clinical Trials | Amphitheatre 125
  • Session 4A (partie 2) - Biomarkers, Biobanking, and Clinical Trials | Amphitheatre 250
  • Cockail | Atrium

 

The following sessions are for PATIENTS (registered on site or via webcast). The conferences will be in english.Simultaneous english-to-french translation will be available for patients sessions (on site only, no simultaneous translation via webcast)

  • Opening remarks and Plenary Lectures 1 & 2 | Amphitheatre 250
  • Session 1B - What we now and still don't know about ME/CFS etiology ans pathomecanism | Amphitheatre 250
  • Session 2B - Advancing ME/CFS Research and Treatment | Amphitheatre 250
  • Session 3B - Groupe de discussion : Meet the experts | Amphitheatre 250
  • Session 4B - Groupe de discussion: Creating a transformative research agenda for ME/CFS | Amphitheatre 250
  • Session 4A Partie 2 (à partir de 16h15) - Biomarkers, Biobanking, and Clinical Trials | Amphitheatre 250
  • Cocktail | Atrium

 

Day 3 - Healthcare community

A roundtable discussion that will focus on developing a collaborative ME/CFS research agenda that includes clinicians and researchers at the national and international levels.

 


A workshop organized by National ME/FM Action Network, is scheduled on the afternoon of Day 1 (May 3rd). The workshop is held at the same time as the conferences. Click here for more details.